您的位置：
首页
>
农业专利
>
详情页
pharmaceutical formulation, device adapted for intranasal delivery of a pharmaceutical formulation, method of treating allergic rhinitis, use of a pharmaceutical formulation, and method for treating inflammatory and / or allergic condition
专利权人:
GLAXO GROUP LIMITED
发明人:
Daren Scott Levin,Diane Michele Ignar
申请号：
BR112015014262
公开号：
BR112015014262A2
申请日:
2013.12.13
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
1/1 summary “pharmaceutical formulation, device adapted for intranasal distribution of a pharmaceutical formulation, treatment method for allergic rhinitis, use of a pharmaceutical formulation, and method The Treatment of Inflammatory and / or Allergic Condition The present invention relates to pharmaceutical formulations comprising an anti-inflammatory glycocorticoid compound of the androstane and levocabastine series, and an antagonist h / antiallergic. The present invention also relates to their therapeutic uses, particularly for the treatment of inflammatory and allergic conditions, specifically rhinitis.1 / 1 resumo “formulaã‡ãƒo farmacãšutica, dispositivo adaptado para distribuiã‡ãƒo intranasal de uma formulaã‡ãƒo farmacãšutica, mã‰todo de tratamento de rinite alã‰rgica, uso de uma formulaã‡ãƒo farmacãšutica, e, mã‰todo para o tratamento de condiã‡ãƒo inflamatã“ria e/ou alã‰rgicaâ€� a presente invenã§ã£o se refere a formulaã§ãµes farmacãªuticas compreendendo um composto glicocorticoide anti-inflamatã³rio da sã©rie de androstano e levocabastina, e um antagonista h /antialã©rgico. a presente 1 invenã§ã£o tambã©m se refere aos usos terapãªuticos destes, particularmente para o tratamento de condiã§ãµes inflamatã³rias e alã©rgicas, especificamente rinite.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
